Código QR (código de barras bidimensional)

Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis

Background: Eosinophilic otitis media (EOM) is a refractory condition associated with eosinophilic chronic rhinosinusitis and bronchial asthma. EOM is characterized by type-2 inflammation and is refractory to various treatments. We investigated the efficacy of dupilumab, interleukin-4 receptor alpha...

ver descrição completa

Na minha lista:
Principais autores: Daiki Nakashima, Tsuguhisa Nakayama, Syunsuke Minagawa, Tetsuya Adachi, Chieko Mitsuyama, Yoko Shida, Tsuneya Nakajima, Shin-ichi Haruna, Yoshinori Matsuwaki
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2023-10-01
coleção:Allergology International
Assuntos:
Eosinophilic otitis media
Eosinophilic chronic rhinosinusitis
Bronchial asthma
Dupilumab
Corticosteroid
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S1323893023000382
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados